Последние новости

Реклама

В.В СКЛЯРЕВИЧ. Антибактериальные лекарственые средства. Методы стандартизации препаратов. Раздел 2

В.В СКЛЯРЕВИЧ. Антибактериальные лекарственые средства. Методы стандартизации препаратов. Страница 155

11. Beneî L. Z, Oie SSchwartz J. В. Design and optimization of dosage

regimens: pharmacokinetic data. — In: Hardman J. G., Limbird L. E., Molinoff P. B., Ruddon R. W., Gilman A. G., ed. Goodman and Gil- man's the pharmacological basis of therapeutics. — 9th ed. — New York: McGraw-Hil, 1996. - P. 1707-1792.

12. Cupp M. J., Tracy T. S. Role of the cytochrome P4503A subfamily in drug interactions // US Pharmacist. — 1997. — Jan — HS9-21.

13. Fromm M. F., Busse D., Kroemer H. K., Eichelbaum M. Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin I I Hepatology. - 1996. -Vol. 24. - P. 796-801.

14. Gillum J. G., Israel D. S., Polk R. E. Pharmacokinetic drug interactions with antimicrobial agents // Clin. Pharmacokinet. — 1993. — Vol. 25 (6). - P. 450-482.

15. Gradelski E., Kolek B., Bonner D. P. et al Activity of gatifloxacin and ciprofloxacin in combination with other antimicrobial agents // Int. J. Antimicrob. Agents. - 2001. - Vol. 17 (2). - P. 103-107.

16. Greiner B., Eichelbaum M., Fritz P. et al The role of intestinal P-glyco- protein in the interaction of digoxin and rifampin // J. Clin. Invest. —

1999. - Vol. 104. - P. 147-153.

17. Guengerich F. P. Cytochrome P-450 3A4: regulation and role in drug metabolism // Annu Rev. Pharmacol. Toxicol. — 1999. — Vol. 39. — P. 1-17.

18. Honig P. K., Woosley R. L., Zamani K. et al Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of teifenadine with concomitant administration of erythromycin // Clin. Pharmacol. Ther. - 1992. - Vol. 52. - P. 231-238.

19 .Johnson J. A., Bootman J. L. Drug-related morbidity and mortality: a cost-of-illness model // Arch. Intern. Med. — 1995. — Vol. 155 (18). - P. 1949-1956.